Resumen de acción 1099
Sinopharm Group Co. Ltd., junto con sus filiales, se dedica a la venta al por mayor y al por menor de productos farmacéuticos, dispositivos médicos y productos sanitarios en la República Popular China.
| Snowflake Score | |
|---|---|
| Valuation | 6/6 |
| Future Growth | 1/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 5/6 |
Recompensas
Análisis de riesgos
No se han detectado riesgos en 1099 a partir de nuestros controles de riesgos.
Competidores de Sinopharm Group Co. Ltd.
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | HK$21.50 |
| 52 Week High | HK$27.60 |
| 52 Week Low | HK$17.44 |
| Beta | 0.83 |
| 1 Month Change | 8.59% |
| 3 Month Change | 3.86% |
| 1 Year Change | -19.32% |
| 3 Year Change | -16.02% |
| 5 Year Change | -28.33% |
| Change since IPO | 16.09% |
Noticias y actualizaciones recientes
Is Sinopharm Group (HKG:1099) A Risky Investment?
Apr 22
Investors Could Be Concerned With Sinopharm Group's (HKG:1099) Returns On Capital
Mar 21Recent updates
Is Sinopharm Group (HKG:1099) A Risky Investment?
Apr 22Investors Could Be Concerned With Sinopharm Group's (HKG:1099) Returns On Capital
Mar 21Should You Think About Buying Sinopharm Group Co. Ltd. (HKG:1099) Now?
Mar 06Is Sinopharm Group Co. Ltd. (HKG:1099) Trading At A 29% Discount?
Jan 31Is Sinopharm Group (HKG:1099) A Risky Investment?
Jan 15There Is A Reason Sinopharm Group Co. Ltd.'s (HKG:1099) Price Is Undemanding
Dec 31Returns On Capital Signal Tricky Times Ahead For Sinopharm Group (HKG:1099)
Nov 29If EPS Growth Is Important To You, Sinopharm Group (HKG:1099) Presents An Opportunity
Nov 14Is Sinopharm Group Co. Ltd. (HKG:1099) Trading At A 28% Discount?
Nov 01Should You Investigate Sinopharm Group Co. Ltd. (HKG:1099) At HK$22.45?
Sep 20Is Sinopharm Group (HKG:1099) Using Too Much Debt?
Sep 05Returns On Capital At Sinopharm Group (HKG:1099) Have Stalled
Aug 18Are Sinopharm Group Co. Ltd. (HKG:1099) Investors Paying Above The Intrinsic Value?
Aug 02Sinopharm Group (HKG:1099) Seems To Use Debt Quite Sensibly
Jun 01Sinopharm Group's (HKG:1099) Returns Have Hit A Wall
Apr 26These 4 Measures Indicate That Sinopharm Group (HKG:1099) Is Using Debt Reasonably Well
Feb 27Sinopharm Group (HKG:1099) Has Some Way To Go To Become A Multi-Bagger
Jan 19Is Sinopharm Group (HKG:1099) A Risky Investment?
Nov 18Returns At Sinopharm Group (HKG:1099) Appear To Be Weighed Down
Oct 03Is Sinopharm Group (HKG:1099) Using Too Much Debt?
Jul 31Estimating The Fair Value Of Sinopharm Group Co. Ltd. (HKG:1099)
Jul 10Slowing Rates Of Return At Sinopharm Group (HKG:1099) Leave Little Room For Excitement
Jun 05We Think Sinopharm Group (HKG:1099) Can Stay On Top Of Its Debt
Apr 11A Look At The Fair Value Of Sinopharm Group Co. Ltd. (HKG:1099)
Mar 21Sinopharm Group (HKG:1099) Hasn't Managed To Accelerate Its Returns
Mar 03Is Sinopharm Group (HKG:1099) Using Too Much Debt?
Jan 09Sinopharm Group Co., Ltd.'s (HKG:1099) Intrinsic Value Is Potentially 28% Above Its Share Price
Dec 19Returns On Capital At Sinopharm Group (HKG:1099) Have Stalled
Dec 01These 4 Measures Indicate That Sinopharm Group (HKG:1099) Is Using Debt Reasonably Well
Sep 23A Look At The Fair Value Of Sinopharm Group Co., Ltd. (HKG:1099)
Sep 10Return Trends At Sinopharm Group (HKG:1099) Aren't Appealing
Aug 28Sinopharm Group (HKG:1099) Is Increasing Its Dividend To HK$0.84
Jun 13Here's Why Sinopharm Group (HKG:1099) Can Manage Its Debt Responsibly
Jun 06Is Sinopharm Group Co., Ltd. (HKG:1099) Expensive For A Reason? A Look At Its Intrinsic Value
May 24Sinopharm Group's (HKG:1099) Returns Have Hit A Wall
May 11Have Insiders Been Selling Sinopharm Group Co., Ltd. (HKG:1099) Shares?
Mar 20We Think Sinopharm Group (HKG:1099) Is Taking Some Risk With Its Debt
Mar 05You Have To Love Sinopharm Group Co., Ltd.'s (HKG:1099) Dividend
Feb 18
Should You Be Impressed By Sinopharm Group's (HKG:1099) Returns on Capital?
Feb 03Should You Use Sinopharm Group's (HKG:1099) Statutory Earnings To Analyse It?
Jan 19At HK$19.00, Is It Time To Put Sinopharm Group Co., Ltd. (HKG:1099) On Your Watch List?
Jan 06What Type Of Shareholders Make Up Sinopharm Group Co., Ltd.'s (HKG:1099) Share Registry?
Dec 25Read This Before Buying Sinopharm Group Co., Ltd. (HKG:1099) Shares
Dec 15We Think Sinopharm Group (HKG:1099) Can Stay On Top Of Its Debt
Dec 04Sinopharm Group's (HKG:1099) Stock Price Has Reduced 43% In The Past Five Years
Nov 25Rentabilidad de los accionistas
| 1099 | HK Healthcare | Mercado HK | |
|---|---|---|---|
| 7D | 9.6% | 3.4% | 4.6% |
| 1Y | -19.3% | -23.0% | -1.1% |
Rentabilidad vs. Industria: 1099 superó a la industria Hong Kong Healthcare, que obtuvo un rendimiento del -27.9% el año pasado.
Rentabilidad vs. Mercado: 1099 obtuvo unos resultados inferiores a los del mercado Hong Kong, que fue del -13.4% el año pasado.
Volatilidad de los precios
| 1099 volatility | |
|---|---|
| 1099 Average Weekly Movement | 4.9% |
| Healthcare Industry Average Movement | 6.7% |
| Market Average Movement | 7.4% |
| 10% most volatile stocks in HK Market | 15.2% |
| 10% least volatile stocks in HK Market | 3.7% |
Precio estable de las acciones: 1099 no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de 1099 (5%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 2003 | 115,959 | Yong Liu | www.sinopharmgroup.com.cn |
Sinopharm Group Co. Ltd., junto con sus filiales, se dedica a la venta al por mayor y al por menor de productos farmacéuticos, dispositivos médicos y productos sanitarios en la República Popular China. La empresa opera a través de cuatro segmentos: Distribución Farmacéutica, Dispositivos Médicos, Farmacia Minorista y Otros Negocios. El segmento de Distribución Farmacéutica distribuye productos farmacéuticos a hospitales, otros distribuidores, farmacias minoristas y clínicas.
Resumen de fundamentos de Sinopharm Group Co. Ltd.
| Estadísticas fundamentales de 1099 | |
|---|---|
| Capitalización bursátil | HK$67.09b |
| Beneficios(TTM) | HK$9.61b |
| Ingresos (TTM) | HK$647.16b |
7.0x
Ratio precio-beneficio (PE)0.1x
Ratio precio-ventas (PS)¿Está 1099 sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de 1099 | |
|---|---|
| Ingresos | CN¥598.32b |
| Coste de los ingresos | CN¥550.17b |
| Beneficio bruto | CN¥48.15b |
| Otros gastos | CN¥39.26b |
| Beneficios | CN¥8.88b |
Últimos beneficios comunicados
Mar 31, 2024
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | 2.85 |
| Margen bruto | 8.05% |
| Margen de beneficio neto | 1.48% |
| Ratio deuda/patrimonio | 62.9% |
¿Cómo se ha desempeñado 1099 a largo plazo?
Ver rendimiento histórico y comparativaDividendos
4.1%
Rentabilidad actual por dividendo31%
Ratio de pagos¿Paga 1099 dividendos fiables?
Ver historial de dividendos e índices de referencia de 1099| fechas de dividendos de Sinopharm Group | |
|---|---|
| Fecha ex dividendo | Jun 17 2024 |
| Fecha de pago de dividendos | Aug 13 2024 |
| Días hasta ex dividendo | 36 days |
| Días hasta la fecha de pago de dividendos | 93 days |
¿Paga 1099 dividendos fiables?
Ver historial de dividendos e índices de referencia de 1099